(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
2.72% $ 4.53
Live Chart Being Loaded With Signals
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease...
Stats | |
---|---|
Dzisiejszy wolumen | 6 874.00 |
Średni wolumen | 49 649.00 |
Kapitalizacja rynkowa | 4.92M |
EPS | $0 ( 2024-04-02 ) |
Następna data zysków | ( $0 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.150 |
ATR14 | $0.0710 (1.57%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-08 | Singer William S. | Buy | 800 | Stock Option (Right to Buy) |
2024-04-08 | Silverman Joshua | Buy | 800 | Stock Option (Right to Buy) |
2024-04-08 | Schechter Jonathan | Buy | 800 | Stock Option (Right to Buy) |
2024-04-08 | Bernstein Bruce | Buy | 800 | Stock Option (Right to Buy) |
2023-03-29 | Schechter Jonathan | Buy | 20 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
74.96 |
Last 71 transactions |
Buy: 1 845 200 | Sell: 283 116 |
Synaptogenix, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
GOSS | 0.958 |
VORB | 0.946 |
BCAB | 0.946 |
THTX | 0.944 |
XFOR | 0.943 |
FATE | 0.942 |
NVTSW | 0.941 |
RIVN | 0.939 |
NCBS | 0.938 |
ISPO | 0.938 |
10 Najbardziej negatywne korelacje | |
---|---|
NWLI | -0.967 |
AMYT | -0.967 |
EZGO | -0.959 |
RXDX | -0.956 |
TACO | -0.956 |
MLCO | -0.955 |
LUNA | -0.954 |
HZNP | -0.953 |
EXAS | -0.953 |
MLVF | -0.953 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Synaptogenix, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-6 347.00 (0.00 %) |
EPS: | $-12.96 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-6 347.00 (0.00 %) |
EPS: | $-12.96 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-5 714.00 (0.00 %) |
EPS: | $-0.780 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.51 |
Financial Reports:
No articles found.
Synaptogenix, Inc.
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; Icahn School of Medicine at Mount Sinai; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is headquartered in New York, New York.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej